Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRTX-100 in persistent/chronic immune thrombocytopenia
NCT02401061Phase 2Terminated
- Sponsor
- Protalex, Inc.
- Start
- Sep 2015
- Primary completion
- Mar 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 2
01
Overview
A Phase 2 trial of staphylococcal protein a in immune thrombocytopenia (ITP), sponsored by Protalex, Inc.. Started Sep 2015; status: terminated.
02
Drugs
staphylococcal protein a
03
Conditions
immune thrombocytopenia (ITP)
Beyond the preview
Go deeper on NCT02401061.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02401061.